Back to results
US 2010/0144732 A1Published application
Pyrimidine kinase inhibitors
OwnerElaine B. Krueger, Thomas E. Rawson +3inventors
InventorsElaine B. Krueger, Thomas E. Rawson, Daniel J. Burdick, Jun Liang, Bing-Yan Zhu
Life of this patent
Estimating the term…
Abstract
The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula I wherein Q, X, Y, Z, R1, R2, R4, m and n are as defined herein.
Claims20
A compound of formula I:
- wherein
- Q is —NR4—, —NR4C(O)—, —C(O)NR4—, —NR4C(O)O—, —OC(O)NR4—, —S(O)2NR4— or —NR4—C(O)—NR4;
- X is H, hydroxyl, halo, amino, nitro, alkyl or haloalkyl;
- Y is O, S or NR4;
- Z is H, alkyl, a carbocycle or a heterocycle, wherein said alkyl, carbocycles and heterocycles are optionally substituted with halogen, hydroxyl, carboxyl, amino, alkyl, a carbocycle or a heterocycle and wherein one or more CH2 groups of an alkyl group is optionally replaced with —O—, —S—, —S(O)—, S(O)2, —NR4—, —C(O)—, —C(O)—NR4—, —NR4—C(O)—, —SO2—NR4—, —NR4—SO2—, —NR4—C(O)—NR4—, —C(O)—O— or —O—C(O)—;
- R1 is hydroxyl, halogen, amino, oxo, thione, alkyl, a carbocycle or a heterocycle wherein said alkyl, carbocycles and heterocycles are optionally substituted with halogen, hydroxyl, carboxyl, amino, alkyl, a carbocycle or a heterocycle and wherein one or more CH2 groups of an alkyl group is optionally replaced with —O—, —S—, —S(O)—, S(O)2, —N(R4)—, —C(O)—, —C(O)—NR4—, —NR4—C(O)—, —SO2—NR4—, —NR4—SO2—, —NR4—C(O)—NR4—, —C(O)—O— or —O—C(O)—;
- R2 is hydroxyl, halogen, amino, carboxyl or is alkyl, acyl, alkoxy or alkylthio optionally substituted with hydroxyl, halogen, oxo, thione, amino, carboxyl or alkoxy;
- R4 is independently H or alkyl;
- m is 0 to 4;
- and
- n is 0 to 3.
8 more elements
Dependencies are inferred from the claim text.